Vitamin D-dependent acne type I is a dubious disease in the field of genetic metabolism, with complex clinical outcomes and often involving multi-system fatigue. Early identification and standardized diagnosis are critical to improving prognosis. The diagnosis of the disease requires a combination of clinical outcomes, imaging inspections, laboratory tests and pathological activation.
A platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic disorders have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment to changes in the course of treatment.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of vitamin D-dependent hepatitis I. The platform serves a team of domestic and foreign experts in the field of genetic metabolism related to the Chinese international medical service system, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.